Ordo puts AI inside lab reports without removing human sign-off

Ordo Labs is building AI software for laboratories where a plausible answer is insufficient. Its system prepares analyses, checks results and drafts study reports, while scientists and quality-assurance staff remain responsible for approving the work.

The company’s launch announcement reports reductions of more than 90% in post-analysis time during paid pilots in the U.S. and Europe. That is a company-reported result, rather than an independently established speed improvement across laboratories. The more concrete proposition is a workflow that connects the report back to the evidence behind it.

A lab can begin with files its instruments already produce. Ordo’s website describes accepting spreadsheets, documents, images and raw exports, preserving the originals and making reported values traceable to their source. The system checks those results against the lab’s procedures and prepares material for review.

Watch Ordo’s original launch demonstration.

The distinction between an AI suggestion and a laboratory decision is explicit. Ordo says qualified people decide whether each quality check passes, with their decision becoming the recorded outcome. A report can then move through signatures and approval before being locked alongside its supporting records.

That design addresses a practical problem for regulated work. A reviewer needs to reconstruct why a result was accepted, including which data and procedures were used. A document that is quick to generate but difficult to inspect simply moves the workload to the person signing it.

Ordo describes separate validation and production environments, with updates reaching production after customer approval. Its website also makes an important qualification: the regulatory frameworks it lists are mappings and documented positions, not certifications it claims to hold. Laboratories still have to validate the system for their own intended use.

The founders bring experience from finance, pharmaceutical workflows and production software. According to their YC profiles, CEO Sebastian Apelgren previously led quantitative research at Handelsbanken. CPO Kristina Hoang co-founded SecureTag, a pharmaceutical authentication platform piloted with Uganda’s National Drug Authority. CTO Adam Tovatt co-founded software consultancy Sakur and worked on backend systems in insurance and financial services.

Ordo belongs to Y Combinator’s Fall 2026 batch. The company says its current workflows cover analysis, quality review and reporting, with a longer-term goal of handling more daily laboratory work on the same validated foundation.

The initial audience includes contract research organizations and contract development and manufacturing organizations, which perform laboratory work for other companies. Ordo says lab executives advise the team and that interviews with more than 100 scientists helped shape the product. Its launch describes reports containing tables, figures and exact source references, rather than a summary detached from the underlying files.

Expansion is meant to happen workflow by workflow. A customer first validates how the software supports a particular job, then builds on that approved foundation. Ordo’s ambition to automate more daily work is a roadmap, not a claim that an entire regulated lab already runs without supervision.

For a prospective customer, the useful question is specific: can a scientist review the generated work faster without losing the ability to trace and defend a result? Ordo’s product puts that review trail at the center of the automation.